M4MM

Silo Pharma Initiates Safety Study for PTSD Drug SPC-15

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...

  • Village Farms International

Village Farms International Reports Q1 2025

LOS ANGELES- Village Farms International Inc. has announced its financial results for the first quarter of 2025, highlighting a strategic pivot towards its cannabis operations and the privatization of certain fresh produce assets. For the ...

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Cronos Group Reports First Quarter 2025

LOS ANGELES- Cronos Group Inc. reported its financial results for the first quarter ended March 31, 2025, indicating a net revenue of $32.3 million, a 28% increase compared to the same period in 2024. The ...

THC Design Repositions for National Expansion

LOS ANGELES- THC Design, a California-based cannabis company, has undertaken a comprehensive rebranding initiative in collaboration with New York creative studio Super Okay. The effort aims to transition the company from a regional entity to ...

Subscribe To Our Newsletter